1.Expert recommendations on human papillomavirus vaccine immunization strategies in China.
Xi Xi ZHANG ; Wen WANG ; Yi Fan SONG ; Zhao Nan ZHANG ; Wen Zhou YU
Chinese Journal of Preventive Medicine 2022;56(9):1165-1174
HPV vaccination is the most effective way for preventing the cervical cancer. To respond the WHO calling for cervical cancer elimination, some Chinese provincial governments are launching the Free HPV Vaccination Programs for teenagers. Basing on the current stage of domestic utilization and the global immunization strategies of HPV vaccination, this paper provides a comprehensive review of the key aspects in the process of HPV vaccination, including subjects and priority vaccination population, vaccination dose and time interval, the principal of vaccination replacement, and the vaccination suggestion on special populations, etc. The article above contents and gives the advice on the immunization strategy of HPV vaccination in China.
AIDS Vaccines
;
Adolescent
;
BCG Vaccine
;
China
;
Diphtheria-Tetanus-Pertussis Vaccine
;
Female
;
Humans
;
Immunization Programs
;
Influenza Vaccines
;
Measles-Mumps-Rubella Vaccine
;
Papillomavirus Infections/prevention & control*
;
Papillomavirus Vaccines
;
Respiratory Syncytial Virus Vaccines
;
SAIDS Vaccines
;
Uterine Cervical Neoplasms
;
Vaccination
2.Analysis for dropout of DTaP routine immunization in China in 2019.
Jia Kai YE ; Lei CAO ; Wen Zhou YU ; Yi Fan SONG ; Zun Dong YIN
Chinese Journal of Preventive Medicine 2022;56(12):1723-1727
Objective: To analyze the dropout of adsorbed diphtheria, tetanus and acellular pertussis combined vaccine (DTaP) routine immunization in China in 2019. Methods: DTaP vaccination data in all counties in China were collected through National Immunization Program Information Management System in 2019. Cumulative dropout rate and vaccination rate of DTaP in different provinces were calculated. According to the P25, P50 and P75 values of DTaP dropout rate for all counties by province, counties in each province were divided into four groups (Q1-Q4). The DTaP average dropout rate of four groups and absolute difference (difference in DTaP average dropout rate between Q4 and Q1) were calculated. Spearman rank correlation was used to analyze the relationship between absolute difference and provincial DTaP dropout rate, DTaP1 and DTaP3 vaccination rate. Results: DTaP1 vaccination rate ranged from 92.98% to 99.94% by province, with a median of 99.55%. Provincial DTaP dropout rate ranged from 0.36% to 28.66%, with a median of 3.54%. The provincial DTaP dropout rate was more than 10% in Gansu and Guizhou, about 28.66% and 17.19%. Absolute difference ranged from 4.02% to 39.22%, with a median of 10.16%. Provinces with the largest absolute difference were Gansu, Qinghai, Liaoning and Guizhou, about 39.22%, 34.48%, 23.31% and 21.33%, respectively. Correlation analysis indicated that the absolute difference was positively correlated with provincial DTaP dropout rate, with a correlation coefficient of 0.492 (P=0.004). It was negatively correlated with DTaP1 and DTaP3 vaccination rate. Correlation coefficients were -0.542 (P=0.001) and -0.562 (P=0.001), respectively. Conclusions: There are significant county-level differences in DTap dropout rate in most provinces, with relatively high difference in western provinces.
Humans
;
Infant
;
Whooping Cough/prevention & control*
;
Diphtheria-Tetanus-Pertussis Vaccine
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Vaccination
;
China
;
Immunization, Secondary
;
Immunization Schedule
;
Antibodies, Bacterial
3.An investigation of vaccination in children with human immunodeficiency virus infection.
Yi-Yun HU ; Ran XIONG ; Hou-Lin TANG ; Jian-Mei HE ; Jun ZHENG ; Ping-Fang ZHANG ; Xi CHEN
Chinese Journal of Contemporary Pediatrics 2019;21(3):199-202
OBJECTIVE:
To investigate the status of vaccination in children with human immunodeficiency virus (HIV) infection.
METHODS:
A questionnaire survey was performed in 148 children in Hunan province, China who were registered in China's Acquired Immune Deficiency Syndrome Comprehensive Response Information Management System up to December 31, 2016 and were aged <15 years at the time of confirmed diagnosis of HIV infection. The information on vaccination, diagnosis of HIV infection, and diagnosis and treatment of related diseases was collected.
RESULTS:
Of the 148 children with HIV infection, there were 70 boys (47.3%) and 78 girls (52.7%); 140 children had an age of 3.8 (0.2-14.8) years at the time of confirmed diagnosis, and 8 children refused to answer this question. Mother-to-child transmission was found in 133 children (91.7%), blood transmission in 1 child (0.7%), and unknown in 14 children (9.5%). Of the 148 children, 129 (87.2%) received antiviral therapy and 19 (12.8%) did not receive such treatment. The vaccination rates of hepatitis B vaccine, bacille Calmette-Guérin vaccine, poliomyelitis live attenuated vaccine and diphtheria-pertussis-tetanus vaccine ranged from 70.9% to 77.7%, which was significantly lower than the national level (≥97%); the vaccination rates of the other vaccines in the National Immunization Program gradually decreased with age. No severe adverse effects were reported after vaccination.
CONCLUSIONS
Mother-to-child transmission is the main route of HIV infection in Chinese children. The diagnosis of children with HIV infection is significantly delayed, with low vaccination rates. Efforts should be made to strengthen early diagnosis, early treatment and vaccination in children with HIV infection, in order to improve their quality of life.
Adolescent
;
Child
;
Child, Preschool
;
China
;
Diphtheria-Tetanus-Pertussis Vaccine
;
Female
;
HIV
;
HIV Infections
;
Humans
;
Infant
;
Male
;
Quality of Life
;
Vaccination
4.A 6-year Prospective, Observational, Multi-Center Post-Marketing Surveillance of the Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Korea
Hee Jin PARK ; Sung Jin KIM ; Rok SONG ; Jing CHEN ; Joon Hyung KIM ; Raghavendra DEVADIGA ; Hee Cheol KANG
Journal of Korean Medical Science 2019;34(12):e105-
BACKGROUND: Incidence of whooping cough is increasing in Korea. Since 2011, occurrence among adolescents and adults has risen putting vulnerable neonates at risk. National immunization guidelines now include Tdap (tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis) vaccination during pregnancy and as a cocooning strategy (i.e., vaccinating adults and adolescents in contact with neonates). This study assessed post-marketing Tdap (Boostrix®, GSK, Belgium) vaccine safety in subjects ≥ 10 years. METHODS: This open, non-comparative multi-center study was conducted over six years at 10 hospitals in Korea. Subjects received Tdap in normal clinical practice according to local prescribing information. All adverse events (AEs) were recorded, classified as expected or unexpected, and severity and relationship to Tdap were assessed. RESULTS: The analysis included 672 Korean subjects (mean age, 44 years; range, 11–81), 451 were women and 211 were pregnant. Ninety subjects experienced 124 AEs (incidence 13.39%) of which six were serious AEs (SAEs) assessed as not related to vaccination, and 51 were non-SAEs related to vaccination (mostly administration site reactions). Overall 65/124 AEs were unexpected; the most common were 14 constipation, 5 dyspepsia, 4 common cold and 4 premature labor cases. One case of common cold was assessed as possibly related to vaccination. Pregnancy outcome was ‘live infant, no apparent congenital anomaly’ in 195 subjects (92.42%) or ‘lost to follow-up’ in 16 subjects. CONCLUSION: Tdap administration to Korean subjects ≥ 10 years, including pregnant women, for the prevention of diphtheria, tetanus and pertussis was shown to have a well-tolerated safety profile. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01929291
Adolescent
;
Adult
;
Common Cold
;
Constipation
;
Diphtheria Toxoid
;
Diphtheria
;
Dyspepsia
;
Female
;
Humans
;
Immunization
;
Incidence
;
Infant
;
Infant, Newborn
;
Korea
;
Obstetric Labor, Premature
;
Pregnancy
;
Pregnancy Outcome
;
Pregnant Women
;
Prospective Studies
;
Tetanus Toxoid
;
Tetanus
;
Vaccination
;
Whooping Cough
5.A survey of the domestic epidemiological characteristics and clinical manifestations of pertussis
Seock Hwa YOON ; Yong Hee HONG ; Hee Kyung LEE ; Jong Hyun LEE ; Meeyong SHIN
Allergy, Asthma & Respiratory Disease 2018;6(1):54-61
PURPOSE: This report describes the results of a survey of the characteristics of pertussis in children from a single institution and compares it to data from the Korea Centers of Disease Control (KCDC). METHODS: We retrospectively evaluated the medical records of 17 and 6 patients diagnosed with pertussis and parapertussis, respectively, at Soonchunhyang University Bucheon Hospital from January 2005 to January 2017. RESULTS: Of the 17 patients with pertussis, 9 were under 1 year of age (52.9%), 3 were aged between 1 and 10 years (17.6%), and 5 were over 10 years of age (29.4%). Seven patients (41.2%) had never received diphtheria-tetanus-acellular pertussis vaccines, of which 5 were infants below 2 months of age and 2 were 10 years old and lived in China. Four patients showed the initial symptoms of cough in China. The sources of infection were the parents (2 cases) and the siblings (8 cases). All patients showed prolonged severe cough and the average duration of cough was 26 days. Severe symptoms, including dyspnea, cyanosis, apnea, and seizures, were observed in the children under 2 months of age. According to the recent 10-year KCDC data, the highest rate of pertussis diagnosis was noted in infants (47.8%), followed by adolescents (18.7%). Six patients with parapertussis also presented with prolonged severe cough without any other severe symptoms. Lymphocytosis was not found, unlike the patients with pertussis. CONCLUSION: The possibility of pertussis and parapertussis should be considered among patients with prolonged severe cough, especially in infants and adolescents.
Adolescent
;
Apnea
;
Bordetella parapertussis
;
Bordetella pertussis
;
Child
;
China
;
Cough
;
Cyanosis
;
Diagnosis
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Dyspnea
;
Gyeonggi-do
;
Humans
;
Infant
;
Korea
;
Lymphocytosis
;
Medical Records
;
Parents
;
Retrospective Studies
;
Seizures
;
Siblings
;
Whooping Cough
6.Clinical features and risk factors of pertussis in children.
Chinese Journal of Contemporary Pediatrics 2018;20(12):1034-1039
OBJECTIVE:
To study the clinical features and risk factors of pertussis in children.
METHODS:
A retrospective analysis was performed for the clinical data and laboratory markers for immune function of 253 hospitalized children with pertussis. A total of 314 hospitalized children with cough were used as the control group. Quantitative real-time PCR was used to detect Bordetella pertussis DNA. The clinical data of both groups were collected to analyze the risk factors for pertussis.
RESULTS:
A total of 23 typical clinical parameters were compared between the pertussis and control groups, and there were significant differences in only 10 clinical parameters between the two groups (P<0.01). As for the complications observed in the two groups, the pertussis group had a significantly lower incidence rate of myocarditis than the control group (P<0.05). The pertussis group had significantly lower levels of serum globulin and IgM than the control group (P<0.05). Compared with the control group, the pertussis group had a significantly higher proportion of children with a lack of diphtheria-pertussis-tetanus immunization or timely immunization and a contact history of suspected pertussis patients (P<0.05). A lack of vaccine immunization or timely immunization and a contact history of suspected pertussis patients were risk factors for pertussis (P<0.05).
CONCLUSIONS
The clinical features are not typical in children with pertussis. Quantitative real-time PCR for detecting Bordetella pertussis DNA helps with the early diagnosis of atypical pertussis. Infants/toddlers should be immunized in time and be isolated from suspected pertussis patients to reduce the incidence of pertussis.
Bordetella pertussis
;
Child
;
Diphtheria-Tetanus-Pertussis Vaccine
;
Humans
;
Retrospective Studies
;
Risk Factors
;
Whooping Cough
7.Knowledge, Attitude and Practice on Maternal Immunization with Tetanus Toxoid, Reduced Diphtheria Toxoid, and Aellular Pertussis (Tdap) among Pregnant Women
Shin Hye LEE ; Bo Kyeung JIN ; Kyeung Suk BAEK ; Yong Sun CHO ; Taek Jin LEE
Pediatric Infection & Vaccine 2018;25(3):141-147
PURPOSE: Despite effectiveness and safety of maternal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccination, Tdap vaccination coverage during pregnancy remains quite low. We assessed the knowledge, attitude and practice on maternal Tdap vaccination among pregnant women. METHODS: This study was a cross-sectional survey of pregnant women who visited tertiary obstetrics and gynecologic units in Seoul and Gyeonggi province of Korea. Individual questionnaires were administered to assess knowledge, attitude and practice on maternal immunization with Tdap. RESULTS: The questionnaires were completed by 184 pregnant women; 158 (86%) had not received information from doctors about pertussis and Tdap, and 166 (90%) did not know the need for Tdap vaccination. Only 7% of pregnant women unlikely to receive Tdap vaccine during current pregnancy answered 3 or more of the 5 knowledge-based questions correctly. By logistic regression analysis, recommendation by doctor (adjusted odd ratio [OR], 236.2; 95% confidence interval [CI], 12.6–4,432), belief that the vaccine is effective (adjusted OR, 40.21; 95% CI, 2.35–687.7), and belief that the vaccine is safe (adjusted OR, 19.83; 95% CI, 1.54–255.9) were significantly important factors to respondents’ intention to be vaccinated. CONCLUSIONS: Most pregnant women seem to be neither recommended nor adequately informed about Tdap vaccination. Information given by health care professionals is very important to increase Tdap coverage among pregnant women.
Cross-Sectional Studies
;
Delivery of Health Care
;
Diphtheria Toxoid
;
Diphtheria
;
Female
;
Gyeonggi-do
;
Humans
;
Immunization
;
Intention
;
Korea
;
Logistic Models
;
Obstetrics
;
Pregnancy
;
Pregnant Women
;
Seoul
;
Tetanus Toxoid
;
Tetanus
;
Vaccination
;
Whooping Cough
8.Evaluation of Potency on Diphtheria and Tetanus Toxoid for Adult Vaccines by In Vivo Toxin Neutralization Assay Using National Reference Standards.
Chan Woong CHOI ; Jae Hoon MOON ; Jae Ok KIM ; Si Hyung YOO ; Hyeon Guk KIM ; Jung Hwan KIM ; Tae Jun PARK ; Sung Soon KIM
Osong Public Health and Research Perspectives 2018;9(5):278-282
OBJECTIVES: Vaccinations against diphtheria and tetanus are essential in providing immunity against these bacterial infections. The potency of diphtheria and tetanus toxoid vaccines can be measured using the in vivo toxin neutralization assay. The limit of potency of this assay was determined only for children. Therefore, we assessed the potency of adult vaccines using this assay to identify the feasibility of limit for adult vaccines. METHODS: Fifteen lots of tetanus-reduced diphtheria and tetanus-diphtheria-acellular pertussis vaccines were used. In vivo toxin neutralization and lethal challenge assays were conducted on each vaccine to calculate the potencies of the toxoids. National reference standards for toxins and antitoxins were used for in vivo toxin neutralization assay. RESULTS: All 15 lots satisfied the limits of potency for lethal challenge assay. The potency of diphtheria and tetanus toxoids exceeded 1 and 8 units/mL, respectively, for in vivo toxin neutralization assay. CONCLUSION: Although additional studies are required for new assays and limits, the current level of potency for adult vaccines as determined by in vivo toxin neutralization assay, was demonstrated in this study. Such efforts to improve assays are expected to promote the development of diphtheria and tetanus vaccines for adults and to contribute to vaccine self-sufficiency.
Adult*
;
Antitoxins
;
Bacterial Infections
;
Child
;
Diphtheria Toxoid
;
Diphtheria*
;
Humans
;
Tetanus Toxoid*
;
Tetanus*
;
Toxoids
;
Vaccination
;
Vaccines*
;
Whooping Cough
9.Investigation of Children with No Vaccinations Recorded on the National Immunization Registry Information System.
Ho Jin NAM ; Sok Goo LEE ; So Youn JEON ; Ji Eun OM ; Kwang Suk PARK
Journal of the Korean Society of Maternal and Child Health 2017;21(3):176-181
PURPOSE: To improve the quality of the vaccination program, analyze the cause and identify the influencing factors for not being registered in the National Immunization Registry Information System even once. METHODS: We conducted one-on-one household visit interview surveys after, using a list supplemented with addresses from the Ministry of the Interior. We identified the basic respondent information, information on relevant children (those born in 2012), the reasons for omission from computerized vaccination registration, and the actual residence of the registered children. RESULTS: The total number of unvaccinated children born in 2012 was 1,870. The final contact result of the household surveys was 1,254 successful contacts, 51 refused to be interviewed, and 565 were not found. The reason for missed vaccination registration was 928 cases of long-term stay overseas, 241 cases of missing registration owing to intentional refusal of vaccination, and 57 cases of illness. A comparison of complete vaccination rates between non-registrants and those of computerized registrants revealed rates of 17.9% and 96.3% for the 3 doses hepatitis B vaccine, 14.9% and 95.6% for the 4doses DTaP vaccine, 16.1% and 97.4% for the 3 doses polio vaccine, and 3.9% and 92.5% for the 3 (or 2) doses Japanese encephalitis vaccine, respectively. CONCLUSION: Vaccination is the most effective national health policy and one of the most remarkable accomplishments in medical history. Through great effort, Korea has started to transcribe vaccination records since 2000, and the records are now reaching a considerable level. However, there is an unregistered population of around 0.3%. Several measures can be taken to improve the registration rate in the vaccination records, such as managing non-registrants through education and interviews, and sharing vaccination data with foreign countries. The non-registrant management plan should include periodically compiling a list of children who are not registered in the National Immunization Registry Information System, conducting of household visits using survey forms, and data analysis to establish appropriate measures.
Child*
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Education
;
Encephalitis, Japanese
;
Family Characteristics
;
Health Policy
;
Hepatitis B Vaccines
;
Humans
;
Immunization*
;
Information Systems*
;
Korea
;
Poliomyelitis
;
Statistics as Topic
;
Surveys and Questionnaires
;
Vaccination*
10.Tetanus–diphtheria–acellular pertussis vaccination for adults: an update.
Clinical and Experimental Vaccine Research 2017;6(1):22-30
Although tetanus and diphtheria have become rare in developed countries, pertussis is still endemic in some developed countries. These are vaccine-preventable diseases and vaccination for adults is important to prevent the outbreak of disease. Strategies for tetanus, diphtheria, and pertussis vaccines vary from country to country. Each country needs to monitor consistently epidemiology of the diseases and changes vaccination policies accordingly. Recent studies showed that tetanus–diphtheria–acellular pertussis vaccine for adults is effective and safe to prevent pertussis disease in infants. However, vaccine coverage still remains low than expected and seroprevalence of protective antibodies levels for tetanus, diphtheria, and pertussis decline with aging. The importance of tetanus–diphtheria–acellular pertussis vaccine administration should be emphasized for the protection of young adult and elderly people also, not limited to children.
Adult*
;
Aged
;
Aging
;
Antibodies
;
Child
;
Developed Countries
;
Diphtheria
;
Diphtheria-Tetanus-acellular Pertussis Vaccines
;
Epidemiology
;
Humans
;
Infant
;
Pertussis Vaccine
;
Seroepidemiologic Studies
;
Tetanus
;
Vaccination*
;
Vaccines
;
Whooping Cough*
;
Young Adult

Result Analysis
Print
Save
E-mail